CA2177721A1 - Taste masked composition containing a drug/polymer complex - Google Patents
Taste masked composition containing a drug/polymer complexInfo
- Publication number
- CA2177721A1 CA2177721A1 CA002177721A CA2177721A CA2177721A1 CA 2177721 A1 CA2177721 A1 CA 2177721A1 CA 002177721 A CA002177721 A CA 002177721A CA 2177721 A CA2177721 A CA 2177721A CA 2177721 A1 CA2177721 A1 CA 2177721A1
- Authority
- CA
- Canada
- Prior art keywords
- chewable
- taste masked
- complex
- therapeutic agent
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6943—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI93A002540 | 1993-12-03 | ||
| ITMI932540A IT1274241B (it) | 1993-12-03 | 1993-12-03 | Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2177721A1 true CA2177721A1 (en) | 1995-06-08 |
Family
ID=11367288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002177721A Abandoned CA2177721A1 (en) | 1993-12-03 | 1994-11-24 | Taste masked composition containing a drug/polymer complex |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0804168A1 (it) |
| JP (1) | JPH09505818A (it) |
| CN (1) | CN1145586A (it) |
| AU (1) | AU693144B2 (it) |
| CA (1) | CA2177721A1 (it) |
| IT (1) | IT1274241B (it) |
| NZ (1) | NZ277238A (it) |
| WO (1) | WO1995015155A1 (it) |
| ZA (1) | ZA949567B (it) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| AU748804B2 (en) * | 1995-07-20 | 2002-06-13 | Smithkline Beecham Plc | Paroxetine controlled release compositions |
| GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
| CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
| US5965555A (en) * | 1996-06-07 | 1999-10-12 | Hoechst Aktiengesellschaft | Xanthine compounds having terminally animated alkynol side chains |
| DE19631084A1 (de) | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut |
| US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
| EE03970B1 (et) | 1997-06-10 | 2003-02-17 | Synthon B.V. | 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim |
| US5955475A (en) * | 1997-06-30 | 1999-09-21 | Endo Pharmaceuticals Inc. | Process for manufacturing paroxetine solid dispersions |
| BR9813808A (pt) * | 1997-12-19 | 2002-05-28 | Smithkline Beecham Corp | Processo para produção de comprimidos para dispersão na mordida |
| IT1298732B1 (it) * | 1998-03-13 | 2000-02-02 | Recordati Chem Pharm | Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| ATE311883T1 (de) | 1999-03-12 | 2005-12-15 | Aesica Pharmaceuticals Ltd | Stabile pharmazeutische anwendungsform für paroxetin-anhydrat |
| WO2003013470A1 (en) * | 2001-08-09 | 2003-02-20 | Smithkline Beecham Plc. | Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| GB0119467D0 (en) * | 2001-08-09 | 2001-10-03 | Smithkline Beecham Plc | Novel compound |
| PT2802311T (pt) * | 2011-10-25 | 2019-03-19 | Expermed S A | Composição farmacêutica sublingual contendo um agente anti-histamínico e método para a sua preparação |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT83241B (pt) * | 1985-08-26 | 1988-07-01 | Searle & Co | Processo para a preparacao de composicoes de drogas de matriz polimerica, capazes de mascarar o sabor de um ingrediente activo, contendo um polimero tendo uma serie de grupos acido e ester carboxilicos |
-
1993
- 1993-12-03 IT ITMI932540A patent/IT1274241B/it active IP Right Grant
-
1994
- 1994-11-24 EP EP95903281A patent/EP0804168A1/en not_active Withdrawn
- 1994-11-24 NZ NZ277238A patent/NZ277238A/en unknown
- 1994-11-24 WO PCT/EP1994/003903 patent/WO1995015155A1/en not_active Ceased
- 1994-11-24 AU AU12198/95A patent/AU693144B2/en not_active Ceased
- 1994-11-24 CA CA002177721A patent/CA2177721A1/en not_active Abandoned
- 1994-11-24 CN CN94194885A patent/CN1145586A/zh active Pending
- 1994-11-24 JP JP7515376A patent/JPH09505818A/ja active Pending
- 1994-12-01 ZA ZA949567A patent/ZA949567B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1219895A (en) | 1995-06-19 |
| WO1995015155A1 (en) | 1995-06-08 |
| EP0804168A1 (en) | 1997-11-05 |
| NZ277238A (en) | 1998-04-27 |
| CN1145586A (zh) | 1997-03-19 |
| IT1274241B (it) | 1997-07-15 |
| AU693144B2 (en) | 1998-06-25 |
| ITMI932540A0 (it) | 1993-12-03 |
| JPH09505818A (ja) | 1997-06-10 |
| ITMI932540A1 (it) | 1995-06-03 |
| ZA949567B (en) | 1995-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1320192C (en) | Pharmaceutical compositions | |
| JP3536106B2 (ja) | 製剤及びその製造方法 | |
| US6649187B2 (en) | Use of polyalkylamine polymers in controlled release devices | |
| AU693144B2 (en) | Taste masked composition containing a drug/polymer complex | |
| US8758779B2 (en) | Pharmaceutical composition of duloxetine | |
| CA1146545A (en) | Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin | |
| DE69419281T2 (de) | Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung | |
| CA2163111C (en) | Process for the preparation of an oral solid dosage form containing diclofenac | |
| US5968906A (en) | Sucralfate preparations | |
| AU739295B2 (en) | Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation | |
| KR100675081B1 (ko) | 아세틸시스테인 함유 경구용 제제 | |
| CA2618187C (en) | Novel resinate complex of s-clopidogrel and production method thereof | |
| SK278519B6 (en) | Water soluble inclusive complex of silybinine together with cyclodextrine, preparation method thereof and pharmaceutical composition contaning that complex | |
| HU204997B (en) | Process for producing carrier system suitable for ensuring controlled biological access to dihydropyridines, as well as new oral dosage form ensuring improved biological access | |
| US5834492A (en) | Water soluble orally effective iron chelator | |
| WO1996002531A1 (en) | Water soluble orally effective iron chelator | |
| AU732785B2 (en) | Process for the preparation of an oral solid dosage form containing diclofenac | |
| GB1596166A (en) | Pharmaceutical compositions | |
| EP0535269A1 (en) | Pharmaceutical compositions containing thiazolidinedione derivatives | |
| Chawan | Preparation and Evaluation of Inclusion Complexes of Water Insoluble Drugs | |
| IE990009A1 (en) | Taste-masked composition | |
| MXPA00001385A (en) | Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |